Smart Radiation Therapy Biomaterials
Name
nihms827292.pdf
Size
708.46 KB
Format
Adobe PDF
Checksum (MD5)
7dced4219a876ab7d2471531dc628b02
Author(s) • • • • • • • • •
Ngwa, Wilfred
Boateng, Francis
Kumar, Rajiv
Formenti, Silvia
Ngoma, Twalib
Herskind, Carsten
Veldwijk, Marlon R.
Hildenbrand, Georg Lars
Wenz, Frederik
Hesser, Juergen
Date Issued
March 2017
Journal
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Citation
Ngwa, Wilfred, Francis Boateng, Rajiv Kumar, Darrell J. Irvine, Silvia Formenti, Twalib Ngoma, Carsten Herskind, et al. “Smart Radiation Therapy Biomaterials.” International Journal of Radiation Oncology*Biology*Physics 97, no. 3 (March 2017): 624–637.
Version
Author's final manuscript
Abstract
Radiation therapy (RT) is a crucial component of cancer care, used in the treatment of over 50% of cancer patients. Patients undergoing image guided RT or brachytherapy routinely have inert RT biomaterials implanted into their tumors. The single function of these RT biomaterials is to ensure geometric accuracy during treatment. Recent studies have proposed that the inert biomaterials could be upgraded to “smart” RT biomaterials, designed to do more than 1 function. Such smart biomaterials include next-generation fiducial markers, brachytherapy spacers, and balloon applicators, designed to respond to stimuli and perform additional desirable functions like controlled delivery of therapy-enhancing payloads directly into the tumor subvolume while minimizing normal tissue toxicities. More broadly, smart RT biomaterials may include functionalized nanoparticles that can be activated to boost RT efficacy. This work reviews the rationale for smart RT biomaterials, the state of the art in this emerging cross-disciplinary research area, challenges and opportunities for further research and development, and a purview of potential clinical applications. Applications covered include using smart RT biomaterials for boosting cancer therapy with minimal side effects, combining RT with immunotherapy or chemotherapy, reducing treatment time or health care costs, and other incipient applications.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Materials Science and Engineering
Massachusetts Institute of Technology. Department of Mechanical Engineering
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/J.IJROBP.2016.10.034